Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging-Reference-Cited by-同舟云学术

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

Published:2017-09-01 Issue:9 Volume:74 Page:1073
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Mielke Michelle M.¹,Hagen Clinton E.²,Wennberg Alexandra M. V.³,Airey David C.⁴,Savica Rodolfo¹,Knopman David S.⁵,Machulda Mary M.⁶,Roberts Rosebud O.¹,Jack Clifford R.⁷,Petersen Ronald C.⁵,Dage Jeffrey L.⁴

Affiliation:

1. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota2Department of Neurology, Mayo Clinic, Rochester, Minnesota

2. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota

3. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota

4. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

5. Department of Neurology, Mayo Clinic, Rochester, Minnesota

6. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota

7. Department of Radiology, Mayo Clinic, Rochester, Minnesota

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment;Experimental Gerontology;2024-10

2. Influence of Tau on Neurotoxicity and Cerebral Vasculature Impairment Associated with Alzheimer’s Disease;Neuroscience;2024-08

3. The omics technologies and liquid biopsies: Advantages, limitations, applications;Medicine in Omics;2024-08

4. Plasma Leptin and Alzheimer Protein Pathologies Among Older Adults;JAMA Network Open;2024-05-03

5. Towards early diagnosis of Alzheimer’s disease: advances in immune-related blood biomarkers and computational approaches;Frontiers in Immunology;2024-04-23